Aussie State Approves Unindicated Use Of Antiviral For Hendra Virus
This article was originally published in PharmAsia News
Australian authorities have begun providing an antiviral for an unindicated use for people exposed to the Hendra virus that is spreading among horses in the country. Four people exposed to the virus were offered Ribavirin developed by Three Rivers Pharmaceuticals and commonly used for treating hepatitis C. Queensland health authorities approved use of the drug in an effort to prevent further infection of humans who may have been in contact with infected horses. One horse-handler died the day after she handled a Hendra-infected horse. (Click here for more
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.